Pharmacotherapy for Neurocognitive Disorders Based on the Hypothesis of Endogenous Appearance of Anticholinergic Activity

Publisher： Karger

E-ISSN： 1660-2862|15|3|157-161

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.15, Iss.3, 2015-06, pp. : 157-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypothesis of Endogenous Anticholinergic Activity in Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. : 149-156

Karger

Access to resources Recommend Favorite

Anticholinergic Activity and Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. : 131-133

Karger

Access to resources Recommend Favorite

Anticholinergic Activity and Schizophrenia

By  

Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. : 168-174

Karger

Access to resources Recommend Favorite

Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain

By  

Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. : 182-187

Karger

Access to resources Recommend Favorite

Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease

By  

Neurodegenerative Diseases, Vol. 15, Iss. 3, 2015-06 ,pp. : 134-139

Karger

Access to resources Recommend Favorite